Functionalized mesoporous silicon for targeted-drug-delivery

Colloids and Surfaces B: Biointerfaces

Volumn 98, Issue , 2012, Pages 18-25

  Tabasi, Ozra ^a   Falamaki, Cavus ^a   Khalaj, Zahra ^b  

^a AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Cytotoxicity; Doxorubicin; Folate; Porous silicon; Targeted drug delivery

Indexed keywords

ANTICANCER DRUG; BY-PRODUCT FORMATION; CELL TOXICITY; COVALENT ATTACHMENT; DICYCLOHEXYLCARBODIIMIDE; DIMETHYLSULFOXIDE SOLUTIONS; DOXORUBICIN; DRUG RELEASE KINETICS; FOLATE; FOLIC ACIDS; FUNCTIONALIZED; MESOPOROUS SILICON; OPTIMAL COMPOSITION; P-SI LAYERS; REACTANT CONCENTRATIONS; SURFACE ACTIVATION; TARGETED DRUG DELIVERY; UNDECYLENIC ACID;

CYTOTOXICITY; DRUG DELIVERY; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POROUS SILICON;

MOLECULES;

10 UNDECENOIC ACID; DICYCLOHEXYLCARBODIIMIDE; DIMETHYL SULFOXIDE; DOXORUBICIN; FOLIC ACID; MACROGOL; MESOPOROUS SILICON; N HYDROXYSUCCINIMIDE; SILICON; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN KB; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); COVALENT BOND; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; MOLECULARLY TARGETED THERAPY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SURFACE PROPERTY;

AMIDES; CARBODIIMIDES; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOHEXANES; DIMETHYL SULFOXIDE; DOXORUBICIN; DRUG CARRIERS; HUMANS; POLYETHYLENE GLYCOLS; POROSITY; SILICON; UNDECYLENIC ACIDS;

EID: 84861464803     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.04.018     Document Type: Article

References (23)

1. Sam S., Touahir L., Salvador Andresa J., Allongue P., Chazalviel J.-N., Gouget-Laemmel A.C., Henry de Villeneuve C., Moraillon A., Ozanam F., Gabouze N., Djebbar S. Langmuir 2010, 26(2):809.
2. Sam S., Chazalviel J.-N., Gouget-Laemmel A.C., Ozanam F., Allongue P., Henry de Villeneuve C., Gabouze N., Djebbar S. Surf. Interface Anal. 2010, 42:515.
3. Lin V.S.-Y., Motesharei K., Dancil K.P.S., Sailor M.J., Ghadiri M.R. Science 1997, 278:840.
4. Azodi M., Falamaki C., Mohsenifar A. J. Mol. Catal. B: Enzym. 2011, 69:1154.
5. Wu E.C., Park J.-H., Park J., Segal E., Cunin F., Sailor M.J. ACS Nano 2008, 2(11):2401.
6. Salonen J., Laitinen L., Kaukonen A.M., Tuura J., Bjorkqvist M., Heikkila T., Vaha-Heikkila K., Hirvonen J., Lehto V.-P. J. Control. Release 2005, 108:362.
7. Laaksonen T., Santos H., Vihola H., Salonen J., Riikonen J., Heikkila T., Peltonen L., Kumar N., Yu Murzin D., Lehto V.-P., Hirvonen J. Chem. Res. Toxicol. 2007, 20:1913.
8. Salonen J., Kaukonen A.M., Hirvonen J., Lehto V.-P. J. Pharm. Sci. 2008, 97(2):632.
9. Mann A.P., Tanaka T., Somasunderam A., Liu X., Gorenstein D.G., Ferrari M. Adv. Mater. 2011, 23:H278.
10. Zhang J., Rana S., Srivastava R.S., Misra R.D.K. Acta Biomater. 2008, 4:40.
11. Mahato R., Tai W., Cheng K. Adv. Drug Deliv. Rev. 2011, 10.1016/j.addr.2011.02.002.
12. Zhang Z., Jia J., Lai Y., Ma Y., Weng J., Sun L. Bioorg. Med. Chem. 2010, 18:5528.
13. Shen Z., Li Y., Kohama K., Oneill B., Bi J. Pharm. Res. 2011, 63:51.
14. Ulbrich K., Michaelis M., Rothweiler F., Knobloch T., Sithisarn P., Cinatl J., Kreuter J. Int. J. Pharm. 2011, 406:128.
15. Rosenholm J.M., Meinander A., Peuhu E., Niemi R., Eriksson J.E., Sahlgren C., Lindeón M. ACS Nano 2009, 3(1):197.
16. Asadishad B., Vossoughi M., Alemzadeh I. Ind. Eng. Chem. Res. 2010, 49:1958.
17. Narayanan S., Binulal N.S., Mony U., Manzoor K., Nair S., Menon D. Nanotechnology 2010, 21. 10.1088/0957-4484/21/28/285107.
18. Salonen J., Lehto V.-P. Chem. Eng. J. 2008, 137:162.
19. Anglin E.J., Cheng L., Freeman W.R., Sailor M.J. Adv. Drug Deliv. Rev. 2008, 60:1266.
20. Pastor E., Salonen J., Lehto V.-P., Chirvony V., Matveeva E. Phys. Stat. Solidi C 2009, 6(7):1704.
21. Moraillon A., Gouget-Laemmel A.C., Ozanam F., Chazaiviel J.-N. J. Phys. Chem. C 2008, 112:7158.
22. Schwartz M.P., Cunin F., Cheung R.W., Sailor M.J. Phys. Stat. Solidi A 2005, 202:1380.
23. Hermanson G.T. Bioconjugate Techniques 2008, Academic Press, (Chapter 13). 2nd ed.